Camrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer.

NCT05624099 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

75

Enrollment

OTHER_GOV

Sponsor class

Conditions

Esophageal Neoplasms
Esophageal Diseases
Digestive System Neoplasms

Interventions

DRUG: camrelizumab
DRUG: Paclitaxel drugs
DRUG: Platinum drug
RADIATION: Radiation

Sponsor

Fujian Cancer Hospital